Asia Fresh News

Asia Fresh Stories

Archive for June 20th, 2011

RS Components Recognised As Top Distributor for Third Consecutive Year

leave a comment »

2011-06-16 12:00
RS Components receives Special Achievement Award for Distributors from Electronics Supply & Manufacturing-China (ESM-China)

SHANGHAI, June 16, 2011 /PRNewswire-Asia/ –RS Components (RS) the world’s largest high service distributor of electronics and maintenance products and the trading brand of Electrocomponents plc (LSE:ECM), has received a “Special Achievement Award” for catalog distributors from Electronics Supply & Manufacturing-China (ESM-China) in conjunction with its 11th Annual Electronic Components Distributor Survey.

This is the third consecutive year that RS has received the award, which further solidifies the company’s lead as the number one high service electronics distributor and distributor of choice in China and the Asia Pacific region. The award is presented to top electronics distributors as voted for by Chinese engineering professionals, including corporate, purchasing and procurement managers from China’s electronics manufacturers.

Apart from being the trusted and reliable source for some 1.6 million engineers and procurement specialists worldwide, RS continues to be the preferred distributor of suppliers across the globe, with an established footprint in 32 countries and a strong network of distributors in a further 37 countries .

With China as one of the key growth markets for RS in the region, the company has recently enhanced its product and service offering to customers through the opening of a new warehouse in Shanghai. The warehouse doubled the size of the original to 4,942 sqm and will provide an extensive and fully stocked inventory of over 135,000 product lines. It is strategically located at Shanghai’s only free trade zone, the Waigaoqiao Free Trade Zone.

“We are very happy to receive this award again from ESM-China and are honoured to know that our customers have continuously supported us through the years. We understand their demands and will continue to invest in China and the Asia Pacific region to further enhance our already high service levels. In addition to improving our local inventory, we have also introduced state of the art forecasting and web demand software to better track and anticipate customer demands,” said Richard Huxley, Regional General Manager, Asia Pacific, at RS Components.

About RS Components

RS Components is the world’s largest distributor of electronics and maintenance products serving 1.6 million customers worldwide. Through operations in 32 countries and 17 warehouses, the Group distributes 550,000 products ranging from semiconductors and optoelectronics to power tools and protective clothing. The product and service portfolio supports the entire product lifecycle from R&D through pre-production to maintenance and repair, shipping more than 40,000 parcels on the same day the orders are received.

RS Components and Allied Electronics are the trading brands of Electrocomponents plc. The Group is listed on the London Stock Exchange and in the last financial year to 31 March 2011 had revenues of £1.18bn. For more information, please visit the website at http://www.rs-components.com.

Contacts:

RS Components
Petrina Seah
External Communications Manager – Asia Pacific
Tel: +65-6391-5719
Email: Petrina.seah@rs-components.com
SOURCE RS Components

Written by asiafreshnews

June 20, 2011 at 8:14 pm

Posted in Uncategorized

Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore

leave a comment »

2011-06-16 09:00
SINGAPORE, June 16, 2011 /PR Newswire-Asia/ — Inviragen announced today the initiation of the first clinical trial of the Company’s proprietary Hand, Foot and Mouth Disease (HFMD) investigational vaccine, INV21, a highly purified virus particle preparation designed to protect against HFMD caused by enterovirus 71 (EV71). The study will be conducted in Singapore at the Investigational Medicine Unit at the National University Health System under Inviragen’s memorandum of understanding with the Duke-NUS Graduate Medical School. This Phase 1 clinical trial of INV21 will assess the safety of the vaccine as well as immune responses in healthy adult volunteers.

“This first clinical study of INV21 is the result of years of research by Inviragen’s scientists, and is an important milestone for our company,” commented Dr. Joseph Santangelo, Inviragen’s chief operating officer. “INV21 was developed in Singapore by Inviragen and our preclinical studies have demonstrated that this vaccine induces broad, neutralizing antibodies to multiple EV71 isolates. Duke-NUS and their strong ties to the hospital community have sped the advance of INV21 into human clinical testing.”

“We are committed to translating basic science into clinical practice with the ultimate goal of bringing vaccines such as INV21 to market for the benefit of people in Singapore and the world,” stated the clinical trial principal investigator Dr. Paul Tambyah, associate professor of the Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore and senior consultant, Division of Infectious Diseases at the National University Hospital, Singapore. “HFMD can be severely debilitating for some children with a risk of paralysis and death. It also remains an ongoing public health threat with significant economic impact as it continues to affect young children in Singapore and the region. We are eager to continue to work with Inviragen to advance the development of INV21, as well as other vaccine candidates.”

The trial is a placebo controlled randomized clinical study and will enroll healthy adults, aged 21 to 45 years. Each individual will receive two immunizations separated by four weeks and will be monitored for any adverse reactions after each administration. Immune responses to INV21 will be measured one, two and six months after the second immunization.

About Hand Foot and Mouth Disease (HFMD)

HFMD is a disease common in children throughout the world. However, the disease is endemic in the Asia Pacific where its incidence has been increasing steadily over the past two decades. Although the disease is typically of short duration, there has been an increase in severe HFMD cases, including central nervous system involvement, associated with EV71. HFMD epidemics have been reported in most Asian countries, particularly Singapore, Taiwan, Malaysia, Vietnam, Korea, Hong Kong and mainland China. Recent reports from the Chinese Ministry of Health revealed more than 1.7 million HFMD infections resulting in 876 deaths from 1 January to 30 November 2010; there were 1.1 million infections with 353 deaths reported for the previous year. In 2010, 30,878 HFMD infections were reported in Singapore, an island nation with a population of approximately five million people, of which roughly 200,000 fall into the most susceptible age group of one-to-five years. No vaccines currently exist for HFMD.

About Inviragen, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen’s vaccines to protect against dengue fever and HFMD are in Phase 1 clinical testing. Vaccines to protect against chikungunya and Japanese encephalitis which affect millions of individuals in Asia, are in clinical manufacturing and development. Vaccines in preclinical research stages include a low-cost human papilloma virus vaccine, vaccines to protect against new forms of influenza and a combination plague/smallpox vaccine for biodefense. Inviragen has offices in Colorado, Wisconsin and Singapore. See http://www.inviragen.com for more details.

About Duke-NUS Graduate Medical School Singapore

The Duke‐NUS Graduate Medical School Singapore (Duke‐NUS) was established in 2005 as a strategic collaboration between the Duke University School of Medicine, located in N. Carolina, USA and the National University of Singapore (NUS). Duke‐NUS offers a graduate entry, 4‐year M.D. (Doctor of Medicine) training programme based on the unique Duke model of education, with one year dedicated to independent study and research projects of a basic science or clinical nature. The first batch of students will graduate in 2011. Duke‐NUS also offers M.D./PhD and PhD programmes. As a player in Singapore’s biomedical community, Duke‐NUS has identified five Signature Research Programmes: Cancer & Stem Cell Biology, Neuroscience and Behavioral Disorders, Emerging Infectious Diseases, Cardiovascular & Metabolic Disorders, and Health Services and Systems Research. For more information, please visit http://www.duke-nus.edu.sg.

Enquires may be directed to:

Media Contact
Aline Schimmel
Media Relations
+1-312-238-8957
aschimmel@scientapr.com Contacts at Inviragen (Singapore) Pte Ltd
Dr. Joseph Santangelo
Chief Operating Officer
+65-6773-8527
jsantangelo@inviragen.com
SOURCE Inviragen, Inc.

Written by asiafreshnews

June 20, 2011 at 2:30 pm

Posted in Uncategorized

SPRG Receives Highest Accolades; Earns “Local Hero – Public Relations Agency of the Year” and “Best PR Campaign – Media Relations” Honours From Marketing Magazine in Hong Kong

leave a comment »

PRNewswire-Asia/ — The largest Asian independent public relations network, Strategic Public Relations Group (“SPRG” or the “Group”), is pleased to receive two grand awards at the Agency of the Year 2011 gala presented by Marketing magazine, highlighting its excellence and professionalism in providing PR services to clients.

(Photo: http://www.prnasia.com/sa/2011/06/17/20110617486871.html )

Local Hero – PR Agency of the Year in Hong Kong

Adding yet another award in its trophy case, SPRG was named “Local Hero 每 Public Relations Agency of the Year” in Hong Kong. The distinctive cube trophy attests to the Group’s firm position in the PR industry, being the largest public relations consultancy in Hong Kong. SPRG has managed many first IPO communications campaigns in recent years, including the listings of companies from Russia, Mongolia, Brazil and Canada. Growing from its financial roots, the Group has expanded its clientele by tapping into consumer PR, event marketing, and brand marketing and communications, resulting in a solid yet diverse portfolio.

Best PR Campaign – Media Relations

The communications programme SPRG developed for United Company RUSAL Plc. (HKEx: 486) was also named “Best PR Campaign – Media Relations” under the MARKies awards, a new award launched by Marketing magazine this year. SPRG executed the PR communications programme for the very first Russian enterprise to list in Hong Kong, and in the process brought the best of Russia to Greater China. With the communications programme reaching out to a wide audience, the Russian listing has become a case study used by The Stock Exchange of Hong Kong Limited to promote Hong Kong as a leading global fundraising platform.

SPRG has already been bestowed with numerous distinctions over the past few years. Chairman and Managing Director of SPRG, Richard Tsang, remarked, “The last eight months have been phenomenal for the Group. We are very proud to be named ‘Local Hero – PR Agency of the Year 2011 in Hong Kong’ by Marketing magazine, repeating our success in 2010. We have also been named ‘Financial Consultancy of the Year’ in 2011 by The Holmes Report and were crowned ‘Asia Pacific Network of the Year’ by Campaign Asia-Pacific PR Awards 2010. All of these accolades underscore SPRG’s success in Hong Kong and Asia. The awards are also an acknowledgement of our professionalism in delivering diverse services to our clients. We will continue to expand beyond our home base across the Asia Pacific region, maintain growth momentum and build on our achievements as we uphold our commitment to being the preferred PR partner of our clients.”

About Marketing magazine’s Agency of the Year Awards

Marketing magazine’s Agency of the Year awards is regarded as the only awards in Asia that is wholly judged by client marketers. It honours agencies with outstanding performance in the industry, judging by their business performance, project performance, staff stability, and leadership and vision. MARKies awards, inaugurated in 2011, is an award to recognise the work across the entire industry. Positioned by the organiser, agencies taking away the signature cube trophies from the Agency of the Year gala awards can rightly call themselves “client preferred” agencies.

About Strategic Public Relations Group

Established in 1995, Strategic Public Relations Group is the largest Asian independent public relations network and the largest public relations consultancy in Hong Kong.

With over 270 professionals working from nine offices in Hong Kong, Beijing, Shanghai, Guangzhou, Taiwan, Singapore and Malaysia, it provides clients, both local and international, with a comprehensive suite of world-class public relations services covering investor relations, corporate and marketing communications, consultancy and event management for automobile, IT, travel and hospitality, healthcare and pharmaceutical brands, luxury, sports and lifestyle service and product promotion, CSR communications, new digital media marketing, B2B communications, conference organisation and event marketing, media skills and presentation training, issues and crisis management, media relations, editorial support and translation and production. With a global affiliation network, SPRG has access to over 100 cities around the world.

In 2009-2011, SPRG is named:

Marketing magazine’s Agency of the Year
— “Local Hero of the Public Relations Agency of the Year” in Hong Kong (2010 & 2011)
— “Best PR Campaign – Media Relations” (2011) (Client: United Company RUSAL Plc.)
— “Local Hero of the Media Relations Agency of the Year” in Hong Kong (2010)

The Holmes Report Asia-Pacific Specialist Agencies of the Year 2011
— “Financial Consultancy of the Year”
The Holmes Report Asia Consultancy Report Card 2009
— “Hong Kong Consultancy of the Year”

Campaign Asia-Pacific PR Awards 2010
— “Asia Pacific Network of The Year”
— “Financial Campaign of The Year” (Client: United Company RUSAL Plc.)

P&G Taiwan
— “Best Integrated Marketing Case in PR Campaign” 2010

PRC Management Science Research Institute
— “The Most Influential Public Relations Consultancy in the PRC 2009”

mergermarket League Tables of PR Advisers
— No.1 PR Adviser to Asia-Pacific Mid-Market M&A: Value (2009)/Volume (2008)

Enquiries
Strategic Public Relations Group
Eveline WAN
Tel: +852-2864-4822
Fax: +852-2114-4948
Email: eveline.wan@sprg.com.hk
Website: http://www.sprg.asia

Member companies: Hong Kong / Beijing / Shanghai / Guangzhou / Taiwan / Singapore /Malaysia

Written by asiafreshnews

June 20, 2011 at 10:47 am

Posted in Uncategorized